Price $11.25 |
Market Cap
38.3M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
3.01
|
P/S
164.75
|
Dividend %
-
|
|
P/CF
68.4
|
P/FCF
-
|
Op. Cash Flow
-2.4K
|
FCF
-0.6
|
|
Op. Margin
-252.90%
|
Net Margin
111.30%
|
ROE
2.20%
|
ROI
-2.80%
|
|
ROA
1.90%
|
EPS Growth
126.80%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $2.83 | - | - | 499.7M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.80 | - | - | 41.2M | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Tempest Therapeutics Inc (TPST) | $15.12 | - | - | 99.7M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.21 | - | - | 42.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
